Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 1961-1972

  Kwong, Peter D ^a   Wyatt, Richard ^b   Sattentau, Quentin J ^d,e   Sodroski, Joseph ^b,c,d   Hendrickson, Wayne A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; OLIGOMER; POLYANION;

ARTICLE; ELECTRICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; STRUCTURE ANALYSIS; VIRUS ADSORPTION;

ELECTROSTATICS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 0033919404     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.1961-1972.2000     Document Type: Article

References (64)

1. Altschul, S., W. Gish, W. Miller, E. Myer, and D. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Baba, M., M. Nakajima, D. Schols, R. Pauwels, J. Balzarini, and E. De Clercq. 1988. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antivir. Res. 9:335-343.
3. Ben-Tal, N., B. Honig, R. M. Peitzsch, G. Denisov, and S. McLaughlin. 1996 Binding of small basic peptides to membranes containing acidic lipids: theoretical models and experimental results. Biophys. J. 71:561-575.
4. Bizebard, T., G. Benoit, P. Rigolet, B. Rasmussen, O. Dial, P. Bosecke, S. Wharton, J. Skehel, and M. Knossow. 1995. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376:92-94.
5. Brunger, A. T. 1993. X-PLOR version 3.1 manual. Yale University, New Haven, Conn.
6. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
7. Catasti, P., E. M. Bradbury, and G. Gupta. 1996. Structure and polymorphism of HIV-1 third variable loops. J. Biol. Chem. 271:8236-8242.
8. Catasti, P., J. D. Fontenot, E. M. Bradbury, and G. Gupta. 1995. Local and global structural properties of the HIV-MN V3 loop. J. Biol. Chem. 270: 2224-2232.
9. Chamow, S., A. Duliege, A. Ammann, J. Kahn, J. Allen, J. Eichberg, R. Byrn, D. Capon, R. Ward, and A. Ashenazi. 1992. CD4 immunoadhesins in anti-HIV therapy: new developments. Int. J. Cancer Suppl. 7:69-72.
10. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
11. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Nat. Struct. Biol. 5:276-279.
12. Dalgleish, A. G., P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
13. Debnath, A. K., S. Jiang, N. Strick, K. Lin, P. Haberfield, and A. R. Neurath. 1994. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type I. J. Med. Chem. 37:1099-1108.
14. Dragic, T., A. Trkola, S. W. Lin, K. A. Nagashima, F. Kajumo, L. Zhao, W. C. Olson, L. Wu, C. R. Mackay, G. P. Allaway, T. P. Sakmar, J. P. Moore, and P. J. Maddon. 1998. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency type 1 entry. J. Virol. 72:279-285.
15. Etemad-Moghadam, B., G. B. Karlsson, M. Halloran, V. Sun, D. Schenten, M. Fernandes, N. L. Letvin, and J. Sodroski. 1998. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys. J. Virol. 72:8437-8445.
16. Farzan, M., H. Choe, E. Desjardins, Y. Sun, J. Kuhn, J. Cao, D. Archambault, P. Kolchinsky, M. Koch, R. Wyatt, and J. Sodroski. 1998. Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J. Virol. 72:7620-7625.
17. Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardin, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, C. Gerard, and J. Sodroski. 1998. A tyrosinerich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164.
18. Farzan, M., T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N. P. Gerard, C. Gerard, J. Sodroski, and H. Choe. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667-676.
19. Fass, D., R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger. 1997. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277:1662-1666.
20. Feng, F., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
21. Gelderblom, H. R., E. H. S. Hausmann, M. Ozel, G. Pauli, and M. A. Koch. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176.
22. Grief, C., D. J. Hockley, C. E. Fromholc, and P. A. Kitchin. 1989. The morphology of simian immunodeficiency virus as shown by negative staining electron microscopy. J. Gen. Virol. 70:2215-2219.
23. Harrop, H. A., D. R. Coombe, and C. C. Rider. 1994. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 8:183-192.
24. Hayashi, K., T. Hayashi, and I. Kojima. 1996. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res. Hum. Retroviru. 12:1463-1471.
25. Hill, C. P., D. Worthylake, D. P. Bancroft, A. M. Christensen, and W. I. Sundquist. 1996. Crystal structure of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA 93:3099-3104.
26. Jansen, R. W., D. Schols, R. Pauwels, E. De Clercq, and D. K. Meijer. 1993. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. Mol. Pharmacol. 44:1003-1007.
27. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the loca-tion of errors in these models. Acta Crystallogr. Sect. A 47:110-119.
28. Kilby, J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M. R. Johnson, M. A. Nowak, G. M. Shaw, and M. S. Saag. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
29. Klatzmann, D., E. Champagne, S. Charmaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
30. Kolchinsky, P., T. Mirzabekov, M. Farzan, E. Kiprilov, M. Cayabyab, L. Mooney, H. Choe, and J. Sodroski. 1999. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. J. Virol. 73:8120-8126.
31. Krust. B., C. Callebaut, and A. G. Hoanessian. 1993. Inhibition of entry of HIV into cells by poly(A) · poly(U). AIDS Res. Hum. Retrovir. 9:1087-1090.
32. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
33. Layne, S., M. Merges, M. Dembo, J. Spouge, and P. Nara. 1990. HIV requires multiple gp120 molecules for CD4-mediated infection. Nature 346: 277-279.
34. McLaughlin, S., and A. Aderem. 1995. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20:272-276.
35. + cells. Science 240:646-649.
36. Mondor, I., S. Ugolini, and Q. J. Sattentau. 1998. Human immunodeficiency virus type 1 attachment to HeLa cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:3623-3634.
37. Moore, J., J. McKeating, W. Norton, and Q. Sattentau. 1991. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implication for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J. Virol. 65:1133-1140.
38. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51-52.
39. Moulard, M., H. Lortat-Jacob, I. Mondor, G. Roca, R. Wyatt, J. Sodroski, P. J. Maddon, W. Olson, P. D. Kwong, and Q. J. Sattentau. 1999. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74:1948-1960.
40. Murray, D., L. Hermida-Matsumoto, C. A. Buser, J. Tsang, C. T. Sigal, N. Ben-Tal, B. Honig, M. D. Resh, and S. McLaughlin. 1998. Electrostatics and the membrane association of Src: theory and experiment. Biochemistry 37: 2145-2159.
41. Nicholls, A., and B. Honig. 1991. A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation. J. Comput. Chem. 12:435-445.
42. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insight from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11:281-296.
43. Patel, M., M. Yanagishita, G. Roderiquez, D. C. Bou-Habib, T. Oravecz, V. C. Hascall, and M. A. Norcross. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retrovir. 9:167-174.
44. Poignard, P., T. Fouts, D. Naniche, J. P. Moore, and Q. J. Sattentau. 1996. Neutralizing antibodies to human immunodeficiency virus type 1 gp120 induce envelope glycoprotein subunit dissociation. J. Exp. Med. 183:473-484.
45. Rizzuto, C, R. Wyatt. N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. Identification of a conserved human immunodeficiency virus gp120 glycoprotein structure important for chemokine receptor binding. Science 280:1949-1953.
46. Ross, T. M., and B. R. Cullen. 1998. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc. Natl. Acad. Sci. USA 95:7682-7286.
47. Sheriff, S., W. A. Hendrickson, R. E. Stenkamp, L. C. Sieker, and L. H. Jensen. 1985. Influence of solvent accessibility and intermolecular contacts on atomic mobilities in hemerythrins. Proc. Natl. Acad. Sci. USA 82:1104-1107.
48. Stanfleld, R. L., E. Cabezas, A. C. Satterthwait, E. A. Stura, A. T. Profy, and I. A. Wilson. 1999. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs. Structure 7:131-142.
49. Staudinger, R., N. G. Abraham, R. D. Levere, and A. Kappas. 1996. Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs. Proc. Assoc. Am. Physicians 108:47-54.
50. Sullivan, N., Y. Sun, J. Binley, J. Lee, C. Barbas III, P. W. H. I. Parren, D. R. Burton, and J. Sodroski. 1998. Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J. Virol. 72:6332-6338.
51. Swart, P. J., E. Beljaars, C. Smit, A. Pasma, H. Schuitemaker, and D. K. Meijer. 1996. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA. J. Drug Target. 4:109-116.
52. Tan, K., J. Lui, J. Wang, S. Shen, and M. Lu. 1997. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94: 12303-12308.
53. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
54. Weis, W., A. Brunger, J. Skehel, and D. Wiley. 1990. Refinement of the influenza virus hemagglutinin by simulated annealing. J. Mol. Biol. 212:737-761.
55. Weissenhorn, W., A. Carfi, K.-H. Lee, J. J. Skehel, and D. C. Wiley. 1998. Crystal structure of the Ebola virus membrane fusion subunit, Gp2, from the envelope glycoprotein ectodomain. Mol. Cell 2:605-616.
56. Weissenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
57. Weisz, P. B., M. M. Joullie, C. M. Hunter, K. M. Kumor, Z. Zhang, E. Levine, E. Macarak, D. Weiner, and E. S. Barnathan. 1997. A basic compositional requirement of agents having heparin-like cell-modulating activities. Biochem. Pharmacol. 54:149-157.
58. Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
59. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 287:366-373.
60. Wu, H., P. D. Kwong, and W. A. Hendrickson. 1997. Dimeric association and segmental variability in the structure of human CD4. Nature 387:527-530.
61. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parlin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
62. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. Sodroski. 1998. The antigenic structure of the human immunodeficiency virus gp120 envelope glycoprotein. Nature 393:705-710.
63. Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski. 1993. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565.
64. Yang, A.-S., and B. Honig. 1999. Sequence to structure alignment in comparative modeling using PrISM. Proteins 37(Suppl. 3):66-72.